Table 3.
Mean difference in several clinical parameters after testosterone replacement therapy as derived from meta-analysis of the available evidence (adapted from reference 14)
MetS: metabolic syndrome, T2DM: type 2 diabetes mellitus, HIV: human immunodeficiency visrus, CKD: chronic kidney diseases, COPD: chronic obstructive pulmonary disease.
*p<0.05, **p<0.005, ***p<0.0001.